These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 9798682)

  • 41. An apoptosis-inducing isoform of neu differentiation factor (NDF) identified using a novel screen for dominant, apoptosis-inducing genes.
    Grimm S; Leder P
    J Exp Med; 1997 Mar; 185(6):1137-42. PubMed ID: 9091587
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heregulin promotes expression and subcellular redistribution of ADP-ribosylation factor 3.
    Li F; Mandal M; Mishra SK; Barnes CJ; Kumar R
    FEBS Lett; 2002 Jul; 524(1-3):49-53. PubMed ID: 12135740
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sensory and motor neuron-derived factor. A novel heregulin variant highly expressed in sensory and motor neurons.
    Ho WH; Armanini MP; Nuijens A; Phillips HS; Osheroff PL
    J Biol Chem; 1995 Nov; 270(44):26722. PubMed ID: 7592900
    [No Abstract]   [Full Text] [Related]  

  • 44. Neu differentiation factor (NDF), a dominant oncogene, causes apoptosis in vitro and in vivo.
    Grimm S; Weinstein EJ; Krane IM; Leder P
    J Exp Med; 1998 Oct; 188(8):1535-9. PubMed ID: 9782131
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 3D stochastic microsensors for molecular recognition and determination of heregulin-α in biological samples.
    Stefan-van Staden RI; Negut CC; Gheorghe SS; Ciorîță A
    Anal Bioanal Chem; 2021 May; 413(13):3487-3492. PubMed ID: 33763747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Erratum to: Heregulin-1ß and HER3 in hepatocellular carcinoma: status and regulation by insulin.
    Buta C; Benabou E; Lequoy M; Régnault H; Wendum D; Merabtene F; Chettouh H; Aoudjehane L; Conti F; Chrétien Y; Scatton O; Rosmorduc O; Praz F; Fartoux L; Desbois-Mouthon C
    J Exp Clin Cancer Res; 2016 Sep; 35(1):154. PubMed ID: 27680564
    [No Abstract]   [Full Text] [Related]  

  • 47. Epigenetic regulation of Neuregulin 1 promotes breast cancer progression associated to hyperglycemia.
    Lee C; Kim M; Park C; Jo W; Seo JK; Kim S; Oh J; Kim CS; Ryu HS; Lee KH; Park J
    Nat Commun; 2023 Jan; 14(1):439. PubMed ID: 36707514
    [TBL] [Abstract][Full Text] [Related]  

  • 48.
    Huang SP; Chen YT; Chen LC; Lee CH; Huang CY; Yu CC; Lin VC; Lu TL; Bao BY
    Biomedicines; 2021 May; 9(5):. PubMed ID: 34068503
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NRG1 fusions in breast cancer.
    Howarth KD; Mirza T; Cooke SL; Chin SF; Pole JC; Turro E; Eldridge MD; Garcia RM; Rueda OM; Boursnell C; Abraham JE; Caldas C; Edwards PAW
    Breast Cancer Res; 2021 Jan; 23(1):3. PubMed ID: 33413557
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuregulin1 acts as a suppressor in human lung adenocarcinoma via AKT and ERK1/2 pathway.
    Wang Y; Ning Z; Zhou X; Yang Z; Tang H; Xu M; Wang X; Zhao J; Bai Y
    J Thorac Dis; 2018 Jun; 10(6):3166-3179. PubMed ID: 30069312
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Copy number changes at 8p11-12 predict adverse clinical outcome and chemo- and radiotherapy response in breast cancer.
    Moelans CB; van Maldegem CMG; van der Wall E; van Diest PJ
    Oncotarget; 2018 Mar; 9(24):17078-17092. PubMed ID: 29682206
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MicroRNAs are part of the regulatory network that controls EGF induced apoptosis, including elements of the JAK/STAT pathway, in A431 cells.
    Alanazi I; Hoffmann P; Adelson DL
    PLoS One; 2015; 10(3):e0120337. PubMed ID: 25781916
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TBX3 over-expression causes mammary gland hyperplasia and increases mammary stem-like cells in an inducible transgenic mouse model.
    Liu J; Esmailpour T; Shang X; Gulsen G; Liu A; Huang T
    BMC Dev Biol; 2011 Oct; 11():65. PubMed ID: 22039763
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DNA methylation changes in a human cell model of breast cancer progression.
    Fernandez SV; Snider KE; Wu YZ; Russo IH; Plass C; Russo J
    Mutat Res; 2010 Jun; 688(1-2):28-35. PubMed ID: 20193695
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The NRG1 gene is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor gene.
    Chua YL; Ito Y; Pole JC; Newman S; Chin SF; Stein RC; Ellis IO; Caldas C; O'Hare MJ; Murrell A; Edwards PA
    Oncogene; 2009 Nov; 28(46):4041-52. PubMed ID: 19802002
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phosphorylation of ErbB4 on tyrosine 1056 is critical for ErbB4 coupling to inhibition of colony formation by human mammary cell lines.
    Pitfield SE; Bryant I; Penington DJ; Park G; Riese DJ
    Oncol Res; 2006; 16(4):179-93. PubMed ID: 17120616
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Roles for neuregulins in human cancer.
    Stove C; Bracke M
    Clin Exp Metastasis; 2004; 21(8):665-84. PubMed ID: 16035612
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Back signaling by the Nrg-1 intracellular domain.
    Bao J; Wolpowitz D; Role LW; Talmage DA
    J Cell Biol; 2003 Jun; 161(6):1133-41. PubMed ID: 12821646
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gamma-heregulin has no biological significance in primary breast cancer.
    Sánchez-Valdivieso EA; Cruz JJ; Salazar R; del Mar Abad M; Gómez-Alonso A; Gómez A; González-Sarmiento R
    Br J Cancer; 2002 Apr; 86(8):1362-3. PubMed ID: 11953899
    [No Abstract]   [Full Text] [Related]  

  • 60. Regulation of mouse mammary gland development and tumorigenesis by the ERBB signaling network.
    Troyer KL; Lee DC
    J Mammary Gland Biol Neoplasia; 2001 Jan; 6(1):7-21. PubMed ID: 11467454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.